Pepdexpepdex
Stack
← All supplements

PEA

Palmitoylethanolamide · Inflammation

ModerateSeveral human trials, smaller or less consistent.

An endogenous fatty-acid amide studied in chronic pain, modest reported benefit, limited adverse-event reporting.

11 trials, 774 people
2023 pooled analysis of double-blind randomised trials reporting lower pain intensity across mixed chronic-pain conditions

What it is

A fatty molecule your own body makes, found in egg yolk, peanuts and soy, and produced on demand in tissue that is inflamed or injured. It is sold for chronic and nerve pain. It is not a painkiller in the usual sense, it does not block pain signals directly and it is not an opioid or an anti-inflammatory drug.

How it works

The proposed mechanism is multi-target and largely worked out in preclinical models rather than people. The most-cited route is switching on PPAR-alpha, a receptor in the cell nucleus that turns down inflammatory gene expression, with additional proposed effects at TRPV1, GPR55 and indirectly on the cannabinoid system, some of which could affect pain signalling directly rather than only through surrounding immune cells. What the trials share is a timescale: they measure effects over weeks rather than hours.

Which form to buy

Ultramicronized PEA (PEA-um)Matching the trial literature

Particle size reduced, which is argued to improve dissolution and exposure. Most positive trials used micronized or ultramicronized branded product, though none compared it head-to-head against the plain form on pain outcomes.

The form most of the evidence used, which is not the same as proof it works better.

Micronized PEA (PEA-m)Same evidence base

Less finely milled than ultramicronized, and also well represented in the trials.

Reasonable and well studied alongside the ultramicronized form.

Naive (non-micronized) PEABudget products

Unprocessed particle size. Micronization is argued to improve dissolution and blood levels, but no head-to-head trial has shown micronized forms produce better pain outcomes than this one.

Less used in the positive trials; clinical superiority of the micronized forms is unproven either way.

PEA with luteolin or other co-factorsProducts chasing a neuroprotection angle

Combination formulas, mostly studied by the same research groups that studied PEA itself.

The added ingredient has far less independent evidence than PEA does.

What it actually does, graded

Studied in chronic painModerate

A 2023 review pooled 11 double-blind randomised trials totalling 774 people and reported lower pain intensity versus control. The caveats matter: conditions, formulations, doses and comparators varied widely, and a large share of the work comes from one research cluster using one branded form.

Studied in nerve-related pain specificallyLimited

The pooled analyses mixed many pain conditions rather than isolating a neuropathic endpoint, so evidence specific to nerve pain is weaker than the overall chronic-pain figure suggests.

Few major adverse events reported in short trialsLimited

Trials were small and short with thin adverse-event reporting, which cannot establish that it is safer than standard pain drugs, rule out uncommon effects, or characterise long-term use.

Works acutely for immediate painNone shown

Not what the trials measured. They assessed effects after sustained daily use, over durations ranging from about ten days to twelve weeks or more.

Replaces prescribed pain managementNone shown

No trial has tested it as a replacement, and nothing here supports stopping a prescribed treatment.

Pros and cons

Pros
  • A mechanism genuinely different from painkillers people have usually already tried
  • Meta-analysis-level evidence, which is rare in a supplement aisle
  • Tolerability in trials was good and dropout for side effects was low
  • Not an opioid, and no dependence signal has been reported in the trials run so far
Cons
  • The evidence concentrates around one research cluster and one branded product
  • Cheap non-micronized products are poorly absorbed and are not what was studied
  • Adverse-event reporting across trials is limited, so tolerability is better described than proven
  • Takes weeks, which is a hard sell when you are in pain now

What to expect

  • Not an acute analgesic, no trial reports a same-day effect.
  • Trial durations ranged from roughly ten days to twelve weeks or longer, so there is no reliable week-by-week pattern to predict from, and no established point at which to judge it a failure.
  • Where trials reported benefit, it was a reduction in pain intensity rather than pain disappearing.

Interactions

MonitorPrescribed pain medicationNo specific interaction is established, but chronic pain treatment should be changed with the prescriber who manages it, not around them.
CautionProduct excipients and allergensFood allergy is triggered by proteins, not by PEA itself occurring naturally in a food, so the molecule is not the concern. What matters is the actual product: check the ingredient and allergen statement for carriers and excipients.
AvoidPregnancy and breastfeedingNo adequate safety data at supplement doses.

Is it for you?

Probably worth it if
  • You are researching options for long-standing pain alongside a clinician and want to know what the trial evidence actually says
  • You can commit to several weeks before judging it
  • You want an option that is not sedating or habit-forming
Probably skip it if
  • You want relief today, this is not that kind of compound
  • You are considering it as a replacement for prescribed pain treatment
  • The product you found does not say micronized or ultramicronized on the label

Who should avoid it

  • Anyone pregnant or breastfeeding
  • Anyone intending to change prescribed pain medication without their prescriber

Research on this supplement

Papers about this supplement, not proof of the claims above. A title says what was studied, which is sometimes a negative result or a different question entirely.

  • Meta-Analysis of Palmitoylethanolamide in Pain Management: Addressing Literature Gaps and Enhancing Understanding
    Nutr Rev, 2025
  • Evaluation of the nutraceutical Palmitoylethanolamide in reducing intraocular pressure (IOP) in patients with glaucoma or ocular hypertension: a systematic review and meta-analysis
    Nat Prod Res, 2025
  • Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-Analysis
    Nutrients, 2024

What the evidence says

Meta-analyses in chronic and neuropathic pain report possible pain reduction, but the underlying studies are small and heterogeneous, several come from one research cluster using one branded form, and adverse-event reporting is limited, so the evidence base is narrower than its size suggests.

What studies used

No established dose. Trials used roughly 300-1,200 mg/day across differing formulations, schedules and pain conditions. Trials typically assessed effects after several weeks of daily use.

Reported from published studies and product labelling — a record of what was used in research, not a recommendation. What is right for you is a conversation with a clinician.

Watch out for

  • Trial durations ran weeks, not days, short-term impressions say little either way
  • Quality varies; the trial evidence is mostly on micronized/ultramicronized material

Evidence base

S21,818 research papers
established literature

Large human evidence base: several phase 3 or 4 trial reports, plus multiple meta-analyses or systematic reviews.

This letter measures how much human research exists, not whether it works for you — the tier above (Moderate) is the read on quality.

Research (12)

Turn PEA into a plan that's yours

The info above is free. Membership makes it personal, the Coach answers questions about your exact stack, the Stack tracks it for you, and the Verified Sources shows you how to vet what you buy.

  • ✓ AI Coach, ask anything about your stack. It does the dosing math, flags interactions, and tells you what to do next.
  • ✓ Personal Stack, save your protocol, track it across devices, log doses, get a heads-up before a vial runs out.
  • ✓ Verified Sources, the vetted reference for checking quality and sourcing, members only.
Become a member, from $4.99/week

Cancel anytime · or save with $59.99/yr · Coach + Stack included

Where next

Every supplement in the catalogThe full shelf, grouped and evidence-tiered.→The compound indexSteroids, nootropics and research chemicals.→The peptide indexInjectable peptides and what trials used.→